Dr. Jannick Dorresteijn is an Internist and Vascular Medicine specialist at University Medical Center Utrecht (NL). He obtained his MD in 2009 and a MSc in Clinical Epidemiology in 2011 at Utrecht University, and completed his PhD cum laude in 2013 on statistical models for personalized cardiovascular prevention.
He has been involved in collaborations within the ESC, e.g. contributions to the development and validation of widely used cardiovascular risk scores, including SCORE2, SCORE2-Diabetes, and the SMART2 Risk Score, which are incorporated into national and international guidelines.
Dr. Dorresteijn is co–principal investigator of the ongoing UCC-SMART cohort study, which investigates cardiovascular risk factors and outcomes in patients with or at risk of atherosclerotic cardiovascular disease. Since 2018, he has led the scientific development and clinical implementation of U-Prevent.com. His work aims to translate scientific innovation into evidence-based patient care.
